Abstract
Depression associated with bipolar disorder in youth is associated with high rates of suicide attempts and significant functional impairment. Three prior studies have examined the efficacy of second-generation antipsychotic (SGA) drugs in youth with bipolar depression. However, findings from these studies have yielded mixed results. We will present findings from a recent study evaluating the efficacy and safety of lurasidone in youth with bipolar depression and will discuss these results in the context of previous studies of SGAs in youth with bipolar depression.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the American Academy of Child & Adolescent Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
